Anemia prevalence in heart failure. GESAIC study results;Prevalencia de la anemia en la insuficiencia cardiaca. Resultados del estudio GESAIC

Revista Clinica Espanola

Volumn 208, Issue 5, 2008, Pages 211-215

  Grau Amoros J ^a,g   Formiga, F ^b   Jordana Comajuncosa, R ^c   Urrutia, A ^d   Aramburu Bodas, O ^e   Ceresuela, L M ^f  

^a Hospital Municipal de Badalona   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c España   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^f HOSPITAL GENERAL DE CATALUNYA   (Spain)

^g Hospital Municipal de Badalona   (Spain)

Author keywords

Anemia; Heart failure; Left ventricular systolic function; Prevalence

Indexed keywords

ANTICOAGULANT AGENT; HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTICLE; BIVARIATE ANALYSIS; CLINICAL PRACTICE; FEMALE; GLOMERULUS FILTRATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN DETERMINATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PROSPECTIVE STUDY; STATISTICAL MODEL; WORLD HEALTH ORGANIZATION;

EID: 44349183239     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1157/13119912     Document Type: Article

References (31)

1. Kalra P, Collier T, Cowie MR, Fox KF, Wood DA, Poole-Wilson PA, et al. Haemoglobin concentration and prognosis in new cases of heart failure. Lancet. 2003;362:211-2.
2. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med. 2003;114:112-9.
3. Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005;45:391-9.
4. Valeur N, Nielsen OW, McMurray JJ, Torp-Pedersen C, Køber L; TRACE Study Group. Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. Eur J Heart Fail. 2006;8:577-84.
5. Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, et al.. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J. 2006;27:1440-6.
6. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, et al; CHARM Committees and Investigators. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation. 2006;113:986-94.
7. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol. 2002;13:1928-36.
8. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarek A, Reczuch K, Kalra PR, et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol. 2003;90:303-8.
9. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes insights from a cohort of 12,065 patients with new-onset heart failure. Circulation. 2003;107:223-5.
10. Formiga F, Chivite D, Castañera O, Manito N, Pujol JMR. Anemia in new-onset congestive heart failure inpatients admitted for acute decompensation. Eur J Intern Med. 2006;17:179-84.
11. Domínguez Franco A, Peña Hernández J, Pérez Caravante M, Muñoz García A, Jiménez Navarro M, de Teresa Galván E. Significado pronóstico a largo plazo de la anemia en una población no seleccionada de pacientes con insuficiencia cardiaca. Med Clin (Barc). 2007;128:370-1.
12. Felker GM, Shaw LK, Stough WG, O'Connor CM. Anemia in patients with heart failure and preserved systolic function. Am Heart J. 2006;151:457-62.
13. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441-6.
14. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Md State Med J. 1965;14:61-5.
15. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficits in the elderly. J Am Geriatr Soc. 1975;23:433-41.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
17. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-47.
18. Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol. 2003;92:625-8.
19. Anand IS, Kuskowski MA, Rector TS, Florea VG, Glazer RD, Hester A, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure. Results from Val-HeFT. Circulation. 2005;112:1121-7.
20. Grigorian-Shamagian L, Varela-Román A, Mazón-Ramos P, Pedreira-Pérez M, Rigueiro-Veloso P, González-Juanatey JR. Anemia como nuevo predictor de la mortalidad de pacientes hospitalizados por IC congestiva. Med Clin (Barc). 2005;125:647-52.
21. García de Casasola G, Cárdenas Franco C, Vegas Serrano A, Hornero Izquierdo MA, Guijarro Herraiz C, Zapatero Gaviria A. La anemia es un factor pronóstico de mortalidad en la insuficiencia cardiaca. An Med Interna (Madrid). 2005;22:271-4.
22. Grigorian-Shamagian L, Varela-Román A, Garcia-Acuña J M, Mazón-Ramos P, Virgos Lamela A, González-Juanatey JR. Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function. Heart. 2006;92:780-4.
23. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-44.
24. Urrutia A, Lupón J, González B, Parajón T, Altimir S, Coll R, et al. Anemia y parámetros relacionados en pacientes de una unidad de IC multidisciplinaria. Med Clin (Barc). 2004;122:121-5.
25. Berry C, Norrie J, Hogg K, Brett M, Stevenson K, McMurray JJ. The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J. 2006;151:1313-21.
26. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the anemia in chronic heart failure: outcomes and resource utilization (ANCHOR) study. Circulation. 2006;113:2713-23.
27. Brucks S, Little WC, Chao T, Rideman RL, Upadhya B, Wesley-Farrington D, et al. Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol. 2004;93:1055-7.
28. Philipp S, Ollmann H, Schink T, Dietz R, Luft FC, Willenbrock R. The impact of anaemia and kidney function in congestive heart failure and preserved systolic function. Nephrol Dial Transplant. 2005;915-9.
29. Agudo de Blas P, Conthe Gutiérrez P, Álvarez de Frutos V, García Peris P, Gil López M, Torres Segovia FJ. Insuficiencia cardíaca, malnutrición e inflamación. Prevalencia y aspectos relevantes en su valoración. Rev Clin Esp. 2006;206:122-8.
30. Kosiborod M, Curtis JP, Wang Y, Smith GL, Masoudi F, Foody JM, et al. Anemia and outcomes in patients with heart failure: a study from the Nacional Heart Care Project. Arch Intern Med. 2005;165:2237-44.
31. Lopes Latado A, Santana Passos LC, Darzé ES, Lopes AA. Comparison of the effect of anemia on in-hospital mortality in patients with versus without preserved left ventricular ejection fraction. Am J Cardiology. 2006;98:1631-4.